EBD GmbH is part of the KNect365 of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
BIO-Europe Spring EBD Group BIO BIO-Europe Spring
Share/Follow Us
Share this:
Follow this event:

BIO-Europe Spring® Press Releases

April 18, 201610th anniversary edition of BIO-Europe Spring® 2016 hosted over 2,300 life science industry executives in Stockholm, Sweden last week The who's who in the life science industry turned out for BIO-Europe Spring® 2016 in Stockholm last week. Over 2,300 executives from 1,377 companies and 49 countries engaged in 12,452 one-to-one meetings to discuss licensing opportunities, deal potential and strategic collaborations. In addition to the one-to-one partnering, the plenary "Environment in 2016: Reverse engineerin...  more ►

April 7, 2016QureTech Bio Wins the 2016 Start-up Slam: Sweden at BIO-Europe Spring ConferenceStart-up Slam is sponsored by Karolinska Institutet Innovations and Johnson & Johnson Innovation
The winner of the Start-up Slam: Sweden, a pitching competition, taking place at BIO-Europe Spring® in Stockholm for the first time on 5 April 2016, was today announced as QureTech Bio AB, a start-up developing first line drugs to combat antibiotic resistance and infectious diseases. This special session was co-sponsored by Karolinska Institutet Innovations AB and Johnson & Jo...  more ►

March 28, 2016Invitation to a Report Launch: Stockholm Business Region to release oncology summary report at BIO-Europe Spring® 2016 During BIO-Europe Spring, Stockholm Business Region is launching the report –Oncology, world-leading research and business opportunities in the Stockholm-Uppsala Region. The report is an oncology summary including the centers of excellence, innovations, current research projects, biobanks and business opportunities in the region. Where: Level 1, Hall 1, Booth #66 When: Monday, April 4...  more ►

March 16, 2016Start-up Slam: 18 early biotechs showcased in special session at BIO-Europe Spring® 2016 Pushing its reputation for taking novel approaches, Karolinska Institutet is bringing together the best and the brightest from Sweden's early academic innovator ecosystem to present their technologies and test their skills in convincing business development executives to support their projects. Some 18 companies from across the country will come together for a competitive session called Start...  more ►

February 2, 2016BIO-Europe Spring® 2016 Event in Sweden this April will bring 2,000+ life science executives to Stockholm-Uppsala region The tenth annual BIO-Europe Spring® springtime international life science partnering conference will be held in Stockholm, Sweden, April 4–6, 2016. Organized by EBD Group, the event is co-hosted by Stockholm Business Region and Stockholm Science City Foundation. The Stockholm-Uppsala region, defined as the three counties of Uppsala, Stockholm and Sörmland, is one of ...  more ►

July 30, 2015Spotlight on Stockholm/Uppsala Region Business Facts The Stockholm-Uppsala region, defined as the three counties of Uppsala, Stockholm and Sörmland, is one of the largest life science clusters in Europe. Stockholm-Uppsala region is Scandinavia's leading life science cluster and one of the world's most productive, and is one of the most competitive business environments in Europe. On average, an astounding 15–20 new...  more ►


partnering360® Blog

June 30, 2016 Industry experts weigh in on Brexit situation and implications for the life science sector partnering360® recently spoke with Alasdair Stamps, Chairman of the Advisory Board and co-Founder of BioPartner UK, and Dr. Claire Skentelbery, Network Manager of Council of European BioRegions and researcher for Scientists for EU, to get their opinions on Brexit and its potential effects on life... more ►

June 21, 2016 Single-use technology means big cost savings for bioprocessing industry What does adoption of single-use technology mean for the bioprocessing industry?   The R&D and manufacturing of biologics and biosimilars is extremely expensive due to the amount of detail necessary to replicate and ensure validation of biosynthesis of living cells and their components. It... more ►

June 16, 2016 Promise of genome and cell therapies move closer to reality Stem cell technologies and adoptive immunotherapies are big buzzwords in the cell therapies world, with the promise of personalized therapies driving interest. Boston is a hotbed for cell and gene therapies potential. STATnews reported today that “several Boston-area hospitals have teamed up with... more ►

June 9, 2016 Surviving as a CMO   What are the key factors for survival as a CMO today? Nordic Life Science has spoken to some Nordic CMOs to get an insight into the current possibilities and challenges. Guest post by Anneli Hidalgo, Nordic Life Science   The pharmaceutical sector is undergoing some dramatic changes,... more ►

June 2, 2016 Entrepreneurship, community and serious tax incentives combine to make Puerto Rico an ideal life science hub If you want a lesson in the opportunities available in Puerto Rico, talk to Ignacio Pino. Pino’s company, CDI Laboratories, Inc., a CRO located in Guanajibo Research and Innovation Park in Puerto Rico, is focused on advanced proteomics. “We are a hybrid CRO as we also call ourselves content... more ►



partnering360:Insight Latest headlines from partnering360:Insight

June 21, 2016 AZ BioVenture Hub CEO says aim is an innovative ecosystem AstraZeneca’s BioVentureHub CEO explains the exchange's vision to generate a climate of open innovation to help grow and nurture the Scandinavian life science ecosystem. more ►

June 21, 2016 Sixth Element Capital outlines healthcare investment strategy Sixth Element Capital's managing partner explains private UK-based group's healthcare investment thinking. more ►

June 20, 2016 RMI says it has USD 200 million already under management The RusnanoMedInvest fund was set up four years ago and has USD 200 million under management in a ten-year closed end fund financed by Russian institutional investors, with 17 separate investments so far. more ►

June 20, 2016 Achelous Partners is built on knowing both life sciences and finance sectors The European Representative of Achelous Partners says the investment bank's proven strategy and strengths are built on parallel knowledge of the life sciences and financial sectors and outlines recent M&A examples. more ►

June 20, 2016 Seventure Partners targets the microbiome revolution Eric de la Fortelle of Seventure Partners explains the VC's new fund that focuses on the microbiome revolution. more ►



Arrow Up

Follow this event:
Sign up now
For news and updates

Privacy Policy and Cookies Terms of Use

Home | Contact Us | Site Map
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2016 EBD GmbH
Privacy Policy and Cookies
Terms of Use